Carbonic Anhydrase Inhibitors
"Carbonic Anhydrase Inhibitors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A class of compounds that reduces the secretion of H+ ions by the proximal kidney tubule through inhibition of CARBONIC ANHYDRASES.
| Descriptor ID |
D002257
|
| MeSH Number(s) |
D27.505.519.389.200
|
| Concept/Terms |
Carbonic Anhydrase Inhibitors- Carbonic Anhydrase Inhibitors
- Inhibitors, Carbonic Anhydrase
- Carbonate Dehydratase Inhibitors
- Inhibitors, Carbonate Dehydratase
- Carboxyanhydrase Inhibitors
- Inhibitors, Carboxyanhydrase
|
Below are MeSH descriptors whose meaning is more general than "Carbonic Anhydrase Inhibitors".
Below are MeSH descriptors whose meaning is more specific than "Carbonic Anhydrase Inhibitors".
This graph shows the total number of publications written about "Carbonic Anhydrase Inhibitors" by people in this website by year, and whether "Carbonic Anhydrase Inhibitors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2004 | 0 | 1 | 1 |
| 2005 | 2 | 0 | 2 |
| 2007 | 1 | 0 | 1 |
| 2016 | 4 | 0 | 4 |
| 2017 | 1 | 1 | 2 |
| 2018 | 2 | 1 | 3 |
| 2020 | 1 | 0 | 1 |
| 2021 | 2 | 0 | 2 |
| 2022 | 0 | 1 | 1 |
| 2024 | 1 | 0 | 1 |
| 2025 | 2 | 0 | 2 |
| 2026 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Carbonic Anhydrase Inhibitors" by people in Profiles.
-
Carbonic Anhydrase Inhibition Sensitizes Group 3 Medulloblastoma to Radiotherapy. Cancer Res. 2025 10 01; 85(19):3737-3751.
-
Anti-breast cancer action of carbonic anhydrase IX inhibitor 4-[4-(4-Benzo[1,3]dioxol-5-ylmethyl-piperazin-1-yl)-benzylidene-hydrazinocarbonyl]-benzenesulfonamide (BSM-0004): in?vitro and in?vivo studies. J Enzyme Inhib Med Chem. 2021 Dec; 36(1):954-963.
-
Five-Year-Old Boy With Behavioral Changes and Papilledema. J Neuroophthalmol. 2018 03; 38(1):75-80.
-
Comparison of Efficacy and Complications of Cyclophotocoagulation and Second Glaucoma Drainage Device After Initial Glaucoma Drainage Device Failure. J Glaucoma. 2017 Nov; 26(11):1010-1018.
-
Discovery of Benzenesulfonamides with Potent Human Carbonic Anhydrase Inhibitory and Effective Anticonvulsant Action: Design, Synthesis, and Pharmacological Assessment. J Med Chem. 2017 03 23; 60(6):2456-2469.
-
Acetazolamide therapy for hypochloremic metabolic alkalosis in pediatric patients with heart disease. Am J Ther. 2007 Jul-Aug; 14(4):331-5.
-
Effect of the carbonic anhydrase inhibitor, acetazolamide, on Helicobacter pylori infection in vivo: a pilot study. Helicobacter. 2005 Apr; 10(2):136-8.
-
Topiramate and metabolic acidosis in pediatric epilepsy. Epilepsia. 2001 Mar; 42(3):387-92.
-
Transformed migraine is a cause of chronic daily headaches. Headache. 1999 Feb; 39(2):95-100.